Who
Sandra G. Stoneman
Chief Legal Officer & Gc
Company insider
Files Form 4 as: Chief Legal Officer & Gc, Immunome.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Nov 2020
- Last trade
- 23 Jul 2026
- Last filed
- 27 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jul 2026filed 27 Jul 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Code A | —38,250 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —76,500 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —76,500 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Code A | —38,250 at $0.00 | filing |
| 29 Jul 2025filed 31 Jul 2025 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —190,000 at $0.00 | filing |
| 9 Aug 2024filed 13 Aug 2024 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —210,000 at $0.00 | filing |
| 31 Jan 2024filed 31 Jan 2024 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 8 Jun 2023filed 12 Jun 2023 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —56,000 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —43,000 at $0.00 | filing |
| 28 May 2021filed 1 Jun 2021 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,609 at $0.00 | filing |
| 3 Nov 2020filed 5 Nov 2020 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —148,837 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.